Federal Official Gazette
No changes.
ANS news
ANS grants special portability to clients of Dr. Dia Planos Odontológicos
ANS has released practical guidance on exercising the special portability granted to beneficiaries of Dr. Dia Planos Odontológicos e Saúde Ltda. To request portability, the beneficiary must present an identity document, CPF (individual taxpayer ID), proof of residence and at least three proofs of payment of monthly fees from October 2024 onward. The ordinary requirements of minimum length of enrollment and price-band compatibility will not be demanded. The Agency clarifies that legal entities that contracted group plans must contract a product from another operator, whereas beneficiaries may exercise portability individually.
Open public consultations
- CP 176. Subject: preliminary recommendations against incorporating the technology covered by UAT No. 184 – Molecular DNA analysis; search for microdeletions by FISH (Fluorescent In Situ Hybridization); microsatellite instability (MSI), detection by PCR, paraffin block, SUBITEM OF DUT – 110.39 – Syndrome of chromosomal abnormalities not clinically recognizable (array). Deadline: September 21 to October 10, 2026.
- CP 177. Subject: preliminary recommendations against incorporating the technologies covered by UAT No. 205 – Implantation of a device for cardiac contractility modulation and UAT No. 209 – 21-gene test for genomic expression profile of breast tumor. Deadline: September 9 to 28, 2026.
Scheduled public hearings
No public hearing is scheduled.
Open public calls for input
There are no open public calls for input.
Open public calls
There are no open public calls or targeted social participation processes.
Other news
Ministry of Health files request with Conitec for analysis of the incorporation of weight-loss pens into SUS
In a publication released on Sep 24, at 6:13 p.m., the Ministry of Health stated that it had submitted to Conitec a request for evaluation of the incorporation of GLP-1 agonist medicines for the treatment of obesity into SUS (the public health system). The proposal refers to semaglutide- or liraglutide-based medicines, active ingredients without patent protection, and takes into account the World Health Organization guideline on the use of these therapies in the long-term treatment of obesity. According to the Ministry, 25 weight-loss pens are already registered in the country, 14 of which were approved in 2026. The Ministry also reports a reduction of approximately 70% in prices in less than a year, attributed to increased competition.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.